Calpeptin: Precision Calpain Inhibitor for Fibrosis Research
2026-04-28
Calpeptin stands apart as a nanomolar calpain inhibitor, delivering reproducible performance in pulmonary fibrosis and inflammation research. This guide unpacks experimental workflows, troubleshooting, and advanced applications that maximize Calpeptin’s utility for translational studies.
CPSIT_0844 Drives IL-6/IL-8 via TLR2/TLR4 and NF-κB in Monoc
2026-04-28
This study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a potent inducer of inflammatory cytokines IL-6 and IL-8 in human monocytes. By dissecting the TLR2/TLR4-MyD88–MAPK/NF-κB axis, the research clarifies a key mechanism underlying C. psittaci immunopathology and informs targeted approaches for inflammatory signaling pathway research.
Synergistic CDK4/6 and BET Inhibition Suppresses Pancreatic
2026-04-27
Gu et al. reveal that combining CDK4/6 and BET inhibitors synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and epithelial-to-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. This work highlights a promising therapeutic strategy and offers mechanistic insight into overcoming limitations of single-agent CDK4/6 inhibition.
Canagliflozin Alters Mitochondria in Diabetic Kidney Disease
2026-04-27
This study demonstrates that canagliflozin, a selective SGLT2 inhibitor, enhances mitochondrial structure and function in proximal tubular cells of hypertensive–diabetic mice. The findings reveal mechanisms beyond glycemic control, suggesting mitochondrial remodeling as a contributor to renal protection in diabetic kidney disease.
Inhibition of CaN/FoxO1/FABP4 Axis Prevents Foam Cell Format
2026-04-26
The referenced study delineates how SERCA2 dysfunction accelerates atherosclerosis via the calcineurin/FoxO1/FABP4 pathway in macrophages, leading to enhanced lipid accumulation and foam cell formation. Targeting this axis—particularly FABP4 inhibition—restores lipid metabolism and reduces atherosclerotic lesion development, informing new therapeutic strategies.
CSBTA Pharmacokinetics and Tissue Distribution in MASH Model
2026-04-25
This study systematically characterizes the pharmacokinetic variability and hepatic distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice with metabolic dysfunction-associated steatohepatitis (MASH). By integrating UHPLC-MS/MS quantification and transporter/metabolic enzyme profiling, the research provides mechanistic insights for rationalizing dosing regimens in MASH and related metabolic disease models.
Angiotensin III: Precision Peptide for RAAS and Cardiovascul
2026-04-24
Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) is unlocking advanced cardiovascular and neuroendocrine research through its robust pressor and aldosterone-inducing actions. With exceptional solubility and validated receptor selectivity, this APExBIO peptide empowers reproducible, high-resolution modeling of RAAS signaling and disease mechanisms.
Indometacin Sodium Trihydrate: Precision Tools for Prostagla
2026-04-24
Explore the scientific versatility of Indometacin Sodium Trihydrate in inflammation and myelin regeneration assays. This article uniquely deciphers its protocol parameters and cross-domain potential, offering actionable guidance for precision anti-inflammatory research.
Assay Reliability with Coagulation Factor II (Thrombin) B Ch
2026-04-23
This article addresses core reproducibility and data quality challenges in cell-based and coagulation assays, focusing on the validated use of Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057). Through scenario-driven Q&A, it guides biomedical researchers in optimizing workflow reliability and experimental sensitivity using this high-purity, assay-ready reagent.
m6A RNA Modification: Antagonistic Plant-Virus Interactions
2026-04-23
This study uncovers a mutually antagonistic mechanism involving N6-methyladenosine (m6A) RNA modification in plant-virus interactions. By dissecting how host and viral factors modulate m6A deposition and recognition, the research provides new insights into the molecular arms race that shapes plant antiviral immunity and viral pathogenicity.
Gepotidacin Phase 2 Study: Efficacy for Uncomplicated Gonorr
2026-04-22
The referenced phase 2 trial evaluates gepotidacin, a novel bacterial type II topoisomerase inhibitor, as a single-dose oral therapy for uncomplicated urogenital gonorrhea. The study demonstrates high efficacy and safety, addressing the urgent need for alternatives to current antibiotic regimens amid rising resistance.
0.4% Trypan Blue Solution: Practical Guide for Cell Viabilit
2026-04-22
0.4% Trypan Blue Solution enables rapid, visual discrimination between live and dead cells, facilitating reliable cell viability measurement in research workflows. It is not suitable for diagnostic or clinical applications, and should only be used where azo dye exclusion principles are appropriate.
Selective Spectrophotometric Analysis of Phenolic β-Lactams
2026-04-21
This study introduces two selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics, including amoxicillin in combination with dicloxacillin, in pure and formulated states. The findings present validated, accessible protocols for routine quality control and pharmaceutical research, filling a gap left by complex chromatographic methods.
Mechanistic Insights into Gepotidacin Action on S. aureus Gy
2026-04-21
This study elucidates the unique mechanism by which Gepotidacin (GSK2140944) inhibits Staphylococcus aureus DNA gyrase, highlighting its differentiation from fluoroquinolones and relevance for antibiotic resistance research. Structural and biochemical analyses reveal Gepotidacin's selective stabilization of single-stranded DNA breaks, informing both drug design and experimental strategies targeting bacterial DNA replication.
10 mM dNTP Mixture: Precision DNA Synthesis & LNP Protocols
2026-04-20
The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture empowers high-fidelity PCR, DNA sequencing, and cutting-edge nucleic acid delivery workflows. Explore how this equimolar, pH-optimized reagent from APExBIO leads to reproducible results and robust troubleshooting across classical and advanced molecular biology applications.
511 records 24/35 page Previous Next First page 上5页 2122232425 下5页 Last page